MAPGen Knowledge Base (MAPGenKB) and Coordination Center
MAPGen Knowledge Base (MAPGenKB) and Coordination Center
批准号:
8692483
负责人:
EDWARD DAVID CRANDALL
金额:
$114.66万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-25 至 2016-06-30
关键词:
BioinformaticsBiologicalBiological MarkersBloodClinicalCommunitiesComputing MethodologiesDNADataData AnalysesDevelopmentDiseaseDisease ProgressionDrug usageFundingGeneticGenomeGoalsHeartHeart DiseasesHematological DiseaseIndividualInformaticsInstructionInternetLeadershipLungLung diseasesManuscriptsMapsMedicalMessenger RNAMolecularNational Heart, Lung, and Blood InstituteOrganPaperPathway interactionsPatientsPharmaceutical PreparationsPhenotypePreparationProcessProteinsProtocols documentationPublic DomainsPublishingQuality ControlRecordsResearchResearch InfrastructureResearch PersonnelReview CommitteeScheduleSleepSleep DisordersTherapeuticWorkabstractingbasebody systemcomputer sciencedatabase of Genotypes and Phenotypesdesigndisorder preventiongenetic analysisinsightknowledge basemeetingsmembernovelnovel diagnosticsnovel strategiesprognosticprogramsresearch studystatisticstherapy designtooltraituser-friendlyweb interface
中文摘要
描述(由申请人提供):我们建议为心脏、肺、血液和睡眠疾病遗传分析的跨器官机制相关表型联盟(MAPGen)开发和实施知识库和协调中心。我们的团队在生物信息学、统计学、计算机科学以及心脏、肺和血液疾病的临床和生物学方面拥有丰富的专业知识。我们建议该中心的三大功能:(1)建立疾病之间相互联系的知识库。我们将系统地识别,整合和分析大量的公共数据(例如NCBI GEO,SRA,dbGap和已发表的论文),以全面描述疾病之间共享的分子机制。我们将建立一个多维的疾病连接地图,可以通过网络界面交互式访问。使用这个知识库,我们将设计计算方法来识别可用于预测一种以上疾病的生物标志物,根据潜在的分子机制对疾病进行重组,设计预测疾病进展的新方法,并识别新的药物用途。(2)为MAPGen联盟开发生物信息学基础设施。我们将负责对联盟产生的数据进行质量控制;我们将对不同RC产生的数据以及来自公共领域的数据进行综合分析,以便对HLBS疾病之间共享的分子机制进行深入了解和基本理解。我们将使用目标1中开发的知识库,进一步建立HLBS与其他疾病之间的联系。我们将与南加州大学的医学合作研究者以及所有RC团队密切合作,以开发和验证生物学假设。(3)我们将建立一个行政中心,协调各驻地协调员的活动,包括协调手稿和其他文件的编写;协调所有委员会的活动;全面研究协调和质量控制;以及管理第3年和第4年额外资金的分配。我们的目标是协同所有RC的努力,以实现理解跨器官疾病之间相互联系的遗传机制的目标。相关性(参见说明):拟议的项目将促进跨器官系统的共同病理生物学特征和机制的识别和表征,并为心脏,肺,血液和睡眠障碍的新诊断,预后和治疗策略的合理,基于机制的发展提供基础。 (End摘要)
英文摘要
DESCRIPTION (provided by applicant): We propose to develop and implement a Knowledge Base and Coordination Center for the Consortium of Cross Organ Mechanism-Associated Phenotypes for Genetic Analyses of Heart, Lung, Blood, and Sleep Diseases (MAPGen). Our team possesses strong expertise in bioinformatics, statistics, computer science, as well as clinical and biological expertise in heart, lung, and blood diseases. We propose three major functions of the center: (1) Develop a knowledge base on interconnections among diseases. We will systematically identify, integrate, and analyze the vast amount of public data (e.g. NCBI GEO, SRA, dbGap, and published papers) to comprehensively describe the shared molecular mechanisms among diseases. We will establish a multi-dimensional disease connectivity map that can be interactively accessed via web- interface. Using this knowledge base, we will design computational approaches to identify biomarkers that can be used to predict more than one disease, to regroup diseases based on the underlying molecular mechanisms, to design novel approaches to predict disease progression, and to identify novel drug usages. (2) Develop a bioinformatics infrastructure for the MAPGen consortium. We will be responsible for the quality control of the data generated by Consortium; we will perform integrative analysis of data generated by different RCs as well those from public domains, in order to gain deep insights and fundamental understandings of the shared molecular mechanisms among the HLBS diseases. We will use the knowledge base developed in Aim 1 to further establish the connections between the HLBS and other diseases. We will work closely with the medical co-investigators at USC as well as all RC teams to develop and validate biological hypotheses. (3) We will establish an Administrative Center to coordinate activities across RCs, including coordination of manuscript and other document preparation; coordination of the activities of all Committees; overall study coordination and quality control; and administering the distribution of additional funds in years 3 and 4. We aim to synergize the effort across all RCs to achieve the goal of understanding the genetic mechanisms responsible for the interconnections among cross-organ diseases. RELEVANCE (See instructions): The proposed projects will facilitate the identification and characterization of common pathobiologic traits and mechanisms cross organ systems, and provide a basis for the rational, mechanism-based development of new diagnostic, prognostic and therapeutic strategies for heart, lung, blood and sleep disorders. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MAPGen Knowledge Base (MAPGenKB) and Coordination Center
-
批准号:8870404
-
项目类别:
-
资助金额:$44.18万
-
财政年份:2011
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
MAPGen Knowledge Base (MAPGenKB) and Coordination Center
-
批准号:8324915
-
项目类别:
-
资助金额:$102.9万
-
财政年份:2011
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
MAPGen Knowledge Base (MAPGenKB) and Coordination Center
-
批准号:8499408
-
项目类别:
-
资助金额:$113.85万
-
财政年份:2011
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
MAPGen Knowledge Base (MAPGenKB) and Coordination Center
-
批准号:8138094
-
项目类别:
-
资助金额:$105.17万
-
财政年份:2011
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Nanoparticle properties and alveolar epithelial barrier/transport functions
-
批准号:8249083
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2009
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Nanoparticle properties and alveolar epithelial barrier/transport functions
-
批准号:7735746
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2009
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Nanoparticle properties and alveolar epithelial barrier/transport functions
-
批准号:8450183
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2009
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Interactions of engineered nanomaterials with lung alveolar epithelium
-
批准号:7938765
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2009
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Nanoparticle properties and alveolar epithelial barrier/transport functions
-
批准号:8063506
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2009
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Interactions of engineered nanomaterials with lung alveolar epithelium
-
批准号:7852903
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2009
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
ABSORPTION MECHANISMS FOR PEPTIDE/PROTEIN DRUGS VIA LUNG
-
批准号:6390641
-
项目类别:
-
资助金额:$64.4万
-
财政年份:1999
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Absorption mechanisms for peptide/protein drugs via lung
-
批准号:6796435
-
项目类别:
-
资助金额:$71.67万
-
财政年份:1999
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
ABSORPTION MECHANISMS FOR PEPTIDE/PROTEIN DRUGS VIA LUNG
-
批准号:6053386
-
项目类别:
-
资助金额:$61.68万
-
财政年份:1999
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
ABSORPTION MECHANISMS FOR PEPTIDE/PROTEIN DRUGS VIA LUNG
-
批准号:6184822
-
项目类别:
-
资助金额:$63.15万
-
财政年份:1999
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
ABSORPTION MECHANISMS FOR PEPTIDE/PROTEIN DRUGS VIA LUNG
-
批准号:6527616
-
项目类别:
-
资助金额:$66.01万
-
财政年份:1999
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
ABSORPTION MECHANISMS FOR PEPTIDE/PROTEIN DRUGS VIA LUNG
-
批准号:6603910
-
项目类别:
-
资助金额:$67.68万
-
财政年份:1999
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Absorption mechanisms for peptide/protein drugs via lung
-
批准号:7458881
-
项目类别:
-
资助金额:$74.4万
-
财政年份:1999
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Absorption mechanisms for peptide/protein drugs via lung
-
批准号:6927132
-
项目类别:
-
资助金额:$73.96万
-
财政年份:1999
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Absorption mechanisms for peptide/protein drugs via lung
-
批准号:7101061
-
项目类别:
-
资助金额:$74.29万
-
财政年份:1999
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
Absorption mechanisms for peptide/protein drugs via lung
-
批准号:7262437
-
项目类别:
-
资助金额:$74.0万
-
财政年份:1999
-
负责人:EDWARD DAVID CRANDALL
-
依托单位:
海外基金